/ /

Cornea OTE

Immune mechanisms in allergic eye diseaseOcular allergy affects the quality of life of millions of people every year. Understanding the different mechanisms involved will increase their future therapeutic options.
Cellular therapy of the corneal stroma: Real approach or science fiction?The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.
Angiography within anterior imagingIt is important with corneal angiography to remember that every patient is different so your technique might very slightly from patient to patient.
Cenegermin receives European Commission marketing authorizationThe European Commission has granted marketing authorisation for cenegermin eye drops (Oxervate, Dompé) for the treatment of moderate to severe neurotrophic keratitis.
Numbers transform dry eye treatment for symptomatic, asymptomatic patientsAdding objective point-of-care dry eye diagnostics to your practice has deep, measurable effects, including more accurate and consistent IOL power calculations.
EMA committee recommends cenegermin for neurotrophic keratitisA committee of the European Medicines Agency has recommended approval of cenegermin (Oxervate, Dompé) eye drops for neurotrophic keratitis.
Rituximab appears to cure Mooren’s ulcers in 5 patientsMooren’s ulcers completely healed in 5 patients treated with rituximab after conventional treatment failed, according to researchers.
Patients’ health jeopardized by failed ophthalmology follow-upFailure to follow-up after ophthalmology appointments can damage patients’ health, a new study suggests. “In our view, national consideration should be given to create targets for reporting how well providers are managing follow-up patients,” reported A Davis and colleagues in the journal Eye.
Aldehyde dehydrogenase implicated in mucous membrane pemphigoidPreliminary studies suggest disulfiram could aid in the treatment of mucous membrane pemphigoid (MMP). Used topically, the drug may inhibit aldehyde deydrogenase (ALDH), which plays a key role in fibrosis, wrote JK Dart, UCL Institute of Ophthalmology, London.
No sign of chloramphenicol resistance in bacterial conjunctivitisChloramphenicol remains effective against Gram-positive bacteria, the most common agent in bacterial conjunctivitis, researchers say.